Announcements Trials
Browse Landscape

Phase

Phase 2/3 1

Status

Completed 166Recruiting 49Unknown 45Terminated 35Active not recruiting 20Not yet recruiting 12Withdrawn 11Suspended 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 3Thoracic 1Head & Neck 1Breast 1

Conditions

Oropharyngeal Neoplasms 1Carcinoma 1

Interventions

Magnetic Resonance Spectroscopy 3Radiotherapy, Intensity-Modulated 2Radiation 2pembrolizumab 1palbociclib 1lenvatinib 1gedatolisib 1dabrafenib 1cemiplimab 1atezolizumab 1Surgical Procedures, Operative 1Specimen Handling 1Radiotherapy, Image-Guided 1Radiotherapy 1Radiosurgery 1Proton Therapy 1Platinum 1Neck Dissection 1Everolimus 1Cisplatin 1Atorvastatin 11,2-diaminocyclohexaneplatinum II citrate 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Suspended × Radiotherapy × Head & Neck × Clear all
NCT05050162 2026-05-07

Comparing Cisplatin Every Three Weeks to Cisplatin Weekly When Combined With Radiation for Patients With Advanced Head and Neck Cancer

NRG Oncology

Phase 2/3 Suspended
1,714 enrolled
Head & Neck

Carcinoma, Oropharyngeal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡